Suppr超能文献

肺炎球菌LytA自溶素,一种在由高度耐β-内酰胺类的肺炎链球菌引起的实验性腹膜炎-脓毒症中有效的治疗剂。

Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniae.

作者信息

Rodríguez-Cerrato Violeta, García Pedro, Huelves Lorena, García Ernesto, Del Prado Gema, Gracia Matilde, Ponte Carmen, López Rubens, Soriano Francisco

机构信息

Department of Medical Microbiology and Antimicrobial Chemotherapy, Fundación Jiménez Díaz, Avenida de Reyes Católicos 2, 28040 Madrid, Spain.

出版信息

Antimicrob Agents Chemother. 2007 Sep;51(9):3371-3. doi: 10.1128/AAC.00137-07. Epub 2007 Jun 18.

Abstract

The in vitro and in vivo antipneumococcal activities of the main pneumococcal autolysin (LytA) and Cpl-1, a lysozyme encoded by phage Cp-1, were studied. Intraperitoneal therapy with LytA or high-dose Cpl-1 remarkably reduced peritoneal bacterial counts (>5 log(10) CFU/ml) compared with those for the controls. After intravenous injection, LytA was the most effective treatment.

摘要

研究了主要肺炎球菌自溶素(LytA)和噬菌体Cp-1编码的溶菌酶Cpl-1的体外和体内抗肺炎球菌活性。与对照组相比,腹腔注射LytA或高剂量Cpl-1可显著降低腹腔细菌计数(>5 log₁₀ CFU/ml)。静脉注射后,LytA是最有效的治疗方法。

相似文献

3
Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by beta-lactam-susceptible and highly resistant pneumococci.
Int J Antimicrob Agents. 2010 Jun;35(6):544-9. doi: 10.1016/j.ijantimicag.2010.02.007. Epub 2010 Mar 19.
4
Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.
J Antimicrob Chemother. 2003 Dec;52(6):967-73. doi: 10.1093/jac/dkg485. Epub 2003 Nov 12.
8
In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases.
Antimicrob Agents Chemother. 2011 Sep;55(9):4144-8. doi: 10.1128/AAC.00492-11. Epub 2011 Jul 11.
9
Epidemiology of antibiotic-resistant Streptococcus pneumoniae strains in Far East Russia.
Int J Antimicrob Agents. 2004 Jun;23(6):641-2. doi: 10.1016/j.ijantimicag.2004.03.005.

引用本文的文献

1
Design of respirable sprayed microparticles of encapsulated bacteriophages.
Front Drug Deliv. 2023 Jun 14;3:1209534. doi: 10.3389/fddev.2023.1209534. eCollection 2023.
2
A new bacteriolytic amidase Ami of Lysobacter capsici XL1.
Sci Rep. 2025 Jul 1;15(1):22257. doi: 10.1038/s41598-025-07691-2.
4
Agents Targeting the Bacterial Cell Wall as Tools to Combat Gram-Positive Pathogens.
Molecules. 2024 Aug 27;29(17):4065. doi: 10.3390/molecules29174065.
7
Synergy Between Two Chimeric Lysins to Kill .
Front Microbiol. 2019 Jun 5;10:1251. doi: 10.3389/fmicb.2019.01251. eCollection 2019.
9
Deciphering how Cpl-7 cell wall-binding repeats recognize the bacterial peptidoglycan.
Sci Rep. 2017 Nov 28;7(1):16494. doi: 10.1038/s41598-017-16392-4.

本文引用的文献

1
Bacteriophage lytic enzymes: novel anti-infectives.
Trends Microbiol. 2005 Oct;13(10):491-6. doi: 10.1016/j.tim.2005.08.007.
2
Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia.
Infect Immun. 2003 Nov;71(11):6199-204. doi: 10.1128/IAI.71.11.6199-6204.2003.
3
Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model.
Antimicrob Agents Chemother. 1996 Dec;40(12):2686-90. doi: 10.1128/AAC.40.12.2686.
5
Specificity of the autolysin of Streptococcus (Diplococcus) pneumoniae.
J Bacteriol. 1974 Feb;117(2):796-804. doi: 10.1128/jb.117.2.796-804.1974.
6
Cloning, purification, and biochemical characterization of the pneumococcal bacteriophage Cp-1 lysin.
J Virol. 1987 Aug;61(8):2573-80. doi: 10.1128/JVI.61.8.2573-2580.1987.
7
Autolysins are direct involved in the bactericidal effect caused by penicillin in wild type and in tolerant pneumococci.
FEMS Microbiol Lett. 1990 Jan 1;54(1-3):317-22. doi: 10.1016/0378-1097(90)90305-a.
8
Immobilization and single-step purification of fusion proteins using DEAE-cellulose.
Eur J Biochem. 1992 Jan 15;203(1-2):153-9. doi: 10.1111/j.1432-1033.1992.tb19840.x.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验